Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENERGIZEKids: Mitapivat in Pediatric Non-Transfusion-Dependent Thalassemia
NCT07517133Phase 3Recruiting
- Sponsor
- Agios Pharmaceuticals
- Start
- Sep 2026
- Primary completion
- Mar 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mitapivat in alpha thalassemia, beta thalassemia, sponsored by Agios Pharmaceuticals. Started Sep 2026; status: recruiting.
02
Drugs
mitapivat
03
Conditions
alpha thalassemiabeta thalassemia
Beyond the preview
Go deeper on NCT07517133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07517133.